ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Comprehensive Centers Could Lose That Designation By Not Producing

May 30, 1975

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

ACS Division Help Fund Some CIS Offices

September 13, 1985

To Wage New War On Cancer, Advocates Plan A Campaign Inspired By Earth Day

October 31, 1997

DRCA Board Split On Use Of Cancer Control Funds By Centers; NCAB Probably Will Decide The Issue

November 26, 1982